| Issue |
Title |
File |
| Vol 95, No 8 (2023) |
Long-term probiotic administration for irritable bowel syndrome: a legal need |
(Rus)
|
|
Solovyeva O.I., Nekrasova A.S., Topalova I.G., Ponomarenko V.A., Tsurtsumiia D.B., Ilyashevich I.G.
|
| Vol 95, No 8 (2023) |
Mild post-COVID syndrome in young patients |
(Rus)
|
|
Ivchenko G.S., Lobzhanidze N.N., Rusina D.S., Denisova E.V., Ivchenko A.A.
|
| Vol 95, No 8 (2023) |
Comparison of the effectiveness of rabeprazole original and generic products in the monotherapy of gastroesophageal reflux disease |
(Rus)
|
|
Krapivnaia O.V.
|
| Vol 95, No 8 (2023) |
The effect of a medicinal plant preparation on the frequency of episodes of exacerbation of recurrent cystitis and metabolic parameters in patients with type 2 diabetes mellitus taking glyphlosins |
(Rus)
|
|
Tsygankova O.V., Evdokimova N.E., Timoshchenko O.V., Latyntseva L.D.
|
| Vol 95, No 8 (2023) |
Cardiovascular risk factors in patients with ulcerative colitis |
(Rus)
|
|
Bicbavova G.R., Drapkina O.M., Livzan M.A., Lisyutenko N.S., Romanyuk A.E.
|
| Vol 95, No 8 (2023) |
Opportunities to improve the prognosis of the course of COVID-19 for at-risk patients |
(Rus)
|
|
Tavlueva E.V., Slyusareva O.A., Panfilova A.A., Markarov A.E.
|
| Vol 95, No 8 (2023) |
The role of structure-modifying agents in the treatment of back pain |
(Rus)
|
|
Shuteeva T.V.
|
| Vol 95, No 8 (2023) |
Use of a controlled attenuation parameter for the diagnosis of non-alcoholic fatty liver disease |
(Rus)
|
|
Goncharov A.A., Sasunova A.N., Pilipenko V.I., Isakov V.A.
|
| Vol 95, No 8 (2023) |
Assessment of body mass index in patients with chronic hepatitis C who received an effective antiviral therapy |
(Rus)
|
|
Dudina K.R., Belyy P.A., Maev I.V., Klimova E.A., Shutko S.A., Znoyko O.O., Yuschuk N.D.
|
| Vol 95, No 8 (2023) |
Drug therapy’s new options in the treatment of the severe irritable bowel syndrome |
(Rus)
|
|
Makarova A.A., Ruchkina I.N., Diukova G.M., Romashkina N.V., Indejkina L.K., Degterev D.A., Parfenov A.I.
|
| Vol 95, No 8 (2023) |
Particularities of arterial stiffness dynamics on the background of breast cancer chemotherapy |
(Rus)
|
|
Yushchuk E.N., Medvedeva E.G., Filonenko D.A., Ivanova S.V., Zhukova L.G., Sapunova D.A.
|
| Vol 95, No 7 (2023) |
Efficacy of dupilumab in real practice in the treatment of severe forms of asthma and atopic dermatitis (comparative retrospective study) |
(Rus)
|
|
Fomina D.S., Fedosenko S.V., Bobrikova E.N., Chernov A.A., Mukhina O.A., Lebedkina M.S., Karaulov A.V., Nurtazina A.Y., Lysenko M.A.
|
| Vol 95, No 7 (2023) |
Effects of sacubitril/valsartan in patients with cancer therapy-related heart failure |
(Rus)
|
|
Vitsenya M.V., Potekhina A.V., Gavryushina S.V., Ibragimova N.M., Stukalova O.V., Masenko V.P., Sharf T.V., Ageev F.T.
|
| Vol 95, No 7 (2023) |
Adherence to treatment of hematological malignancies patients with anxiety and depression |
(Rus)
|
|
Vybornykh D.E., Moiseeva T.N., Gemdzhian E.G., Gaponova T.V., Esina L.V., Kolgaeva E.I., Novikova D.V.
|
| Vol 95, No 7 (2023) |
Association between cardio-ankle vascular index and markers of thrombosis in hospitalized patients COVID-19 |
(Rus)
|
|
Podzolkov V.I., Bragina A.E., Tarzimanova A.I., Ogibenina E.S., Shvedov I.I., Ivannikov A.A., Megeneishvili N.К., Sutulova A.V.
|
| Vol 95, No 7 (2023) |
The survival prediction of hospitalized patients with COVID-19: the role of chitotriosidase level in peripheral blood |
(Rus)
|
|
Schelkanovtseva E.S., Isaev G.O., Mironova O.Y., Balakhonov A.A., Skvortsov A.V., Nagornov I.O., Suvorov A.Y., Fomin V.V., Panferov A.S.
|
| Vol 95, No 7 (2023) |
Features of the course and adverse events risk of coronavirus infection COVID-19 in hematological diseases (data from the CHRONOS19 register for the Primorsky Territory, intermediate stage) |
(Rus)
|
|
Talko A.V., Nevzorova V.A., Dubov V.S., Muzychenko N.S., Gurbanov E.R., Dubov S.K., Beniova S.N., Simakova A.I.
|
| Vol 95, No 9 (2023) |
Effect of dapagliflozin on the dynamics of magnetic resonance imaging in patients with heart failure and atrial fibrillation |
(Rus)
|
|
Saipudinova K.M., Uskach T.M., Shariya M.А., Ustyuzhanin D.V., Dobrovolskaya S.V., Tereshchenko S.N.
|
| Vol 95, No 6 (2023) |
Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study |
(Rus)
|
|
Lebedkina M.S., Fomina D.S., Mutovina Z.Y., Mаrkina U.A., Bogomolov P.O., Chulanov V.P., Lysenko M.A., Alexeeva E.I.
|
| Vol 95, No 6 (2023) |
Potential for infusion correction of COVID-19-associated endotheliopathy |
(Rus)
|
|
Simutis I.S., Ratnikov V.A., Scheglov A.N., Nikolaeva O.V., Boyarinov G.A., Sapegin A.A., Gaikovaya L.B., Evteeva D.A., Zamyatina K.N.
|
| Vol 95, No 6 (2023) |
Prevalence, age and gender features of chronic kidney disease in patients with diabetes mellitus |
(Rus)
|
|
Murkamilov I.T., Aitbaev K.A., Fomin V.V.
|
| Vol 95, No 6 (2023) |
Comparative characteristics of the complement system in patients with C3-glomerulopathy and atypical hemolytic uremic syndrome of chronic course who suffered an acute episode of thrombotic microangiopathy |
(Rus)
|
|
Yurova V.A., Kozlovskaya N.L., Bobrova L.A., Kozlov L.V., Andina S.S., Demyanova K.A.
|
| Vol 95, No 6 (2023) |
Clinical significance of uremic toxin indoxyl sulfate and inflammation in the development of vascular calcification and cardiovascular complications in stage C3–C5D chronic kidney disease |
(Rus)
|
|
Dzgoeva F.U., Remizov O.V., Goloeva V.G., Ikoeva Z.R.
|
| Vol 95, No 6 (2023) |
Clinical significance of the determination of antibodies to thrombospondin type 1 containing domain 7A (THSD7A) in membranous nephropathy |
(Rus)
|
|
Kakhsurueva P.A., Kamyshova E.S., Bobkova I.N., Stavrovskaya E.V., Rudenko T.E., Andreeva E.Y.
|
| Vol 95, No 6 (2023) |
Study of urinary markers of different podocytopathies by proteomic analysis |
(Rus)
|
|
Vinogradov A.A., Chebotareva N.V., Bugrova A.E., Brzhozovskiy A.G., Krasnova T.N., Nasibullina K.Z., Kononikhin A.S., Moiseev S.V.
|
| Vol 95, No 5 (2023) |
The structure of post/long COVID fatigue syndrome. Prospects for correction |
(Rus)
|
|
Kuznetsova P.I., Tanashyan M.M., Raskurazhev A.A., Zaslavskaya K.I.
|
| Vol 95, No 5 (2023) |
Comparative assessment of sensitivity and specificity of three variants of classification criteria for systemic lupus erythematosus in a cohort of Russian patients |
(Rus)
|
|
Reshetnyak T.M., Lisitsyna T.A., Cheldieva F.A., Shumilova A.A., Glukhova S.I., Starovoytova M.N., Seredavkina N.V., Desinova O.V., Verizhnikova Z.G., Nasonov E.L.
|
| Vol 95, No 5 (2023) |
A new integral enthesial-comorbididity index of psoriatic arthritis activity |
(Rus)
|
|
Korsakova Y.L., Korotaeva T.V., Loginova E.Y., Gubar E.E., Vorobyeva L.D., Glukhova S.I., Nasonov E.L.
|
| Vol 95, No 5 (2023) |
Physical activity and nutritional status in women with rheumatoid arthritis and sarcopenic phenotype of body composition |
(Rus)
|
|
Dobrovolskaya O.V., Feklistov A.Y., Demin N.V., Kozyreva M.V., Toroptsova N.V.
|
| Vol 95, No 5 (2023) |
Mental disorders in patients with systemic lupus erythematosus: association with activity and the course of rheumatic disease |
(Rus)
|
|
Borisova A.B., Lisitsyna T.A., Veltishchev D.Y., Reshetnyak T.M.
|
| Vol 95, No 5 (2023) |
Diastolic dysfunction of ventricles in patients with calcium pyrophosphate crystal deposition disease while receiving anti-inflammatory therapy |
(Rus)
|
|
Eliseev M.S., Zheliabina O.V., Kirillova I.G., Korsakova Y.O.
|
| Vol 95, No 5 (2023) |
Long-term use of glucocorticoids in patients with active rheumatoid arthritis: therapeutic "freeze frame" |
(Rus)
|
|
Gordeev A.V., Matyanova E.V., Galushko E.A.
|
| Vol 95, No 5 (2023) |
Subclinical atherosclerosis of the carotid arteries in patients with rheumatoid arthritis with low cardiovascular risk |
(Rus)
|
|
Gerasimova E.V., Popkova T.V., Shalygina M.V., Kirillova I.G., Gerasimova D.A., Glukhova S.I., Nasonov E.L.
|
| Vol 95, No 4 (2023) |
Endoscopic and morphometric analysis of the reduction of acute inflammatory process in the gastric mucosa after therapy with Regasthym Gastro |
(Rus)
|
|
Baryshnikova N.V., Uspenskiy Y.P., Fominykh Y.A., Petlenko S.V., Zaplutanov V.A., Apryatina V.A., Krasnov A.A.
|
| Vol 95, No 4 (2023) |
Possibilities for the use of ursodeoxycholic acid in the treatment of patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease |
(Rus)
|
|
Rasskazova M.A., Vorobyev S.V., Butova H.N.
|
| Vol 95, No 4 (2023) |
Type 2 diabetes mellitus and coronary artery disease: features of perfusion volume computed tomography of the heart in a pharmacological test with adenosine triphosphate |
(Rus)
|
|
Soboleva G.N., Minasyan A.A., Gaman S.A., Rogoza A.N., Molina L.P., Soboleva T.V., Shariya M.A., Ternovoy S.K., Karpov Y.A.
|
| Vol 95, No 4 (2023) |
The levels of certain circulating microRNAs in hypertrophic cardiomyopathy are associated with echocardiographic parameters |
(Rus)
|
|
Pisklova M.V., Baulina N.M., Kiselev I.S., Zateyshchikov D.A., Favorova O.O., Chumakova O.S.
|
| Vol 95, No 4 (2023) |
Prognostic value of periprocedural dynamics of left ventricular ejection fraction and subclinical pulmonary congestion in patients with myocardial infarction |
(Rus)
|
|
Timofeeva T.M., Kobalava Z.D., Safarova A.F., Cabello Montoya F.
|
| Vol 95, No 3 (2023) |
Efficacy and safety of patients immunization with chronic obstructive pulmonary disease with monoclonal antibodies |
(Rus)
|
|
Antonov V.N., Ignatova G.L.
|
| Vol 95, No 3 (2023) |
Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronchitis |
(Rus)
|
|
Zaitsev A.A., Leshchenko I.V., Esaulova N.A., Viktorova I.A.
|
| Vol 95, No 3 (2023) |
Possibilities of non-invasive diagnosis of fibrotic phenotype of interstitial lung diseases |
(Rus)
|
|
Shchepikhin E.I., Shmelev E.I., Ergeshov A.E., Zaytseva A.S., Shergina E.A., Adamovskaya E. .
|
| Vol 95, No 3 (2023) |
Interstitial pneumonia with autoimmune features: monocentric prospective study |
(Rus)
|
|
Akulkina L.A., Shchepalina A.A., Moiseev A.S., Brovko M.Y., Sholomova V.I., Moiseev S.V.
|
| Vol 95, No 3 (2023) |
Clinic and functional features of chronic obstructive pulmonary disease after virus-induced acute exacerbations. |
(Rus)
|
|
Shpagina L.A., Kotova O.S., Shpagin I.S., Karmanovskaya S.A., Loktin E.M., Rukavitsyna A.A., Kuznetsova G.V., Gerasimenko D.A., Anikina E.V.
|
| Vol 95, No 3 (2023) |
Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease |
(Rus)
|
|
Trushenko N.V., Stoliarevich A.A., Andriukov B.G., Nuralieva G.S., Tsareva N.A., Lavginova B.B., Avdeev S.N.
|
| Vol 95, No 2 (2023) |
Assessment of the possible impact of hepatitis viruses on the development and course of autoimmune liver diseases |
(Rus)
|
|
Sbikina E.S., Vinnitskaya E.V., Batskikh S.N., Sandler Y.G., Saliev K.G., Khaimenova T.Y., Bordin D.S.
|
| Vol 95, No 2 (2023) |
Irritable bowel syndrome phenotypes: leading factors of genetics and epigenetics, mechanisms of formation |
(Rus)
|
|
Gaus O.V., Livzan M.A.
|
| Vol 95, No 2 (2023) |
Liver damage in children and adolescents with newly diagnosed celiac disease: clinical and anamnestic, serological and morphological patterns |
(Rus)
|
|
Cherkasova E.A., Klimov L.Y., Kuryaninova V.A., Yagupova A.V., Ivenskaya T.A., Gliva A.V.
|
| Vol 95, No 2 (2023) |
Features of the upper gastrointestinal tract mucous membrane state in patients with atherosclerosis of the mesenteric arteries |
(Rus)
|
|
Selyanina A.A., Dolgushina A.I., Kusnezowa A.S., Genkel V.V., Olevskaya E.R., Nikushkina K.V., Khikhlova A.O.
|
| Vol 95, No 2 (2023) |
The course and clinical manifestations of Peutz–Jeghers syndrome in the Russian population |
(Rus)
|
|
Savelyeva Т.A., Ponomarenko А.A., Shelygin Y.A., Kuzminov А.M., Vyshegorodtsev D.V., Loginova А.N., Pikunov D.Y., Goncharova Е.P., Likutov А.A., Mainovskaya О.A., Tsukanov А.S.
|
| Vol 95, No 2 (2023) |
The effect of the FODMAP and rebamipid diet on the activity of disaccharidases in patients with enteropathy with impaired membrane digestion |
(Rus)
|
|
Baulo E.V., Belostotsky N.I., Akhmadullina O.V., Dbar S.R., Bykova S.V., Parfenov A.I.
|
| 51 - 100 of 435 Items |
<< < 1 2 3 4 5 6 7 8 9 > >>
|
